MENU
+Compare
IGMS
Stock ticker: NASDAQ
AS OF
Dec 24, 12:47 PM (EDT)
Price
$6.30
Change
-$0.21 (-3.23%)
Capitalization
410.3M

IGMS IGM Biosciences Forecast, Technical & Fundamental Analysis

a biotechnology company, which develops antibodies for the treatment of cancer

Industry Biotechnology
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for IGMS with price predictions
Dec 23, 2024

Momentum Indicator for IGMS turns negative, indicating new downward trend

IGMS saw its Momentum Indicator move below the 0 level on December 11, 2024. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned negative. In of the 83 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for IGMS turned negative on December 13, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IGMS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for IGMS entered a downward trend on December 19, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IGMS advanced for three days, in of 293 cases, the price rose further within the following month. The odds of a continued upward trend are .

IGMS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.904) is normal, around the industry mean (14.519). P/E Ratio (0.000) is within average values for comparable stocks, (86.885). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.760). IGMS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (135.135) is also within normal values, averaging (257.834).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. IGMS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IGMS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

IGMS is expected to report earnings to fall 27.33% to -73 cents per share on March 27

IGM Biosciences IGMS Stock Earnings Reports
Q4'24
Est.
$-0.73
Q3'24
Missed
by $0.21
Q2'24
Missed
by $0.75
Q1'24
Missed
by $0.02
Q4'23
Est.
$-1.01
The last earnings report on November 08 showed earnings per share of -100 cents, missing the estimate of -80 cents. With 31.83K shares outstanding, the current market capitalization sits at 410.30M.
A.I. Advisor
published General Information

General Information

a biotechnology company, which develops antibodies for the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
325 East Middlefield Road
Phone
+1 650 965-7873
Employees
224
Web
https://www.igmbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PJRQX7.520.05
+0.67%
PGIM Quant Solutions International Eq R6
JEMWX30.800.17
+0.56%
JPMorgan Emerging Markets Equity R6
TVLIX11.950.02
+0.17%
Touchstone Value Institutional
PMPIX47.870.07
+0.15%
ProFunds Precious Metals UltraSector Inv
JDSAX22.810.01
+0.04%
Janus Henderson Small Cap Value A

IGMS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IGMS has been loosely correlated with MDGL. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if IGMS jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGMS
1D Price
Change %
IGMS100%
-5.65%
MDGL - IGMS
42%
Loosely correlated
+0.79%
ABCL - IGMS
39%
Loosely correlated
+2.46%
FATE - IGMS
37%
Loosely correlated
-1.19%
BTAI - IGMS
37%
Loosely correlated
+1.58%
GBIO - IGMS
37%
Loosely correlated
-7.56%
More